About BELKIN Vision
BELKIN Vision is a company based in Yavne (Israel) founded in 2013 was acquired by Alcon in July 2024.. BELKIN Vision has raised $14.75 million across 5 funding rounds from investors including Alcon, Santen Pharmaceuticals and European Union. BELKIN Vision offers products and services including DSLT and Hydrus Microstent. BELKIN Vision operates in a competitive market with competitors including ViaLase, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
- Headquarter Yavne, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alcon Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BELKIN Vision
BELKIN Vision offers a comprehensive portfolio of products and services, including DSLT and Hydrus Microstent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers laser pulses to treat glaucoma and lower intraocular pressure.
Improves aqueous outflow in glaucoma patients for pressure reduction.
Unlock access to complete
Unlock access to complete
Funding Insights of BELKIN Vision
BELKIN Vision has successfully raised a total of $14.75M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2.84 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $2.8M
-
First Round
First Round
(01 Sep 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Grant - BELKIN Vision | Valuation |
investors |
|
| Jul, 2020 | Amount | Series B - BELKIN Vision | Valuation | Rimonci , Santen Pharmaceuticals | |
| Jun, 2017 | Amount | Series A - BELKIN Vision | Valuation | Rimonci , Zicom Group |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BELKIN Vision
BELKIN Vision has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, Santen Pharmaceuticals and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Rimonci's activities.
|
Founded Year | Domain | Location | |
|
ZIG Ventures is focused on healthcare innovation investments.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BELKIN Vision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BELKIN Vision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Belkin Vision Comparisons
Competitors of BELKIN Vision
BELKIN Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaLase, ELIOS Vision, Radiance Therapeutics and EyeLight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Image-guided femtosecond laser devices for glaucoma treatments are developed.
|
|
| domain | founded_year | HQ Location |
Excimer laser technology is applied to develop glaucoma therapy devices.
|
|
| domain | founded_year | HQ Location |
Beta ophthalmic applicator for glaucoma surgery is developed.
|
|
| domain | founded_year | HQ Location |
Develops patented treatment methods for glaucoma.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Belkin Vision
Frequently Asked Questions about BELKIN Vision
When was BELKIN Vision founded?
BELKIN Vision was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is BELKIN Vision located?
BELKIN Vision is headquartered in Yavne, Israel. It is registered at Yavne, Central District, Israel.
Is BELKIN Vision a funded company?
BELKIN Vision is a funded company, having raised a total of $14.75M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Sep 01, 2016.
What does BELKIN Vision do?
BELKIN Vision was founded in 2013 in Yavne, Israel, where a laser device known as Vision DSLT is developed for glaucoma management. The device is designed for non-invasive, non-contact application, delivering laser energy to the limbus to improve intraocular fluid drainage and reduce pressure. Treatment is provided for open-angle and angle-closure glaucoma, with operations focused on medical device innovation in the ophthalmology sector. The companys domain is belkin-vision.com.
Who are the top competitors of BELKIN Vision?
BELKIN Vision's top competitors include ViaLase, ELIOS Vision and Radiance Therapeutics.
What products or services does BELKIN Vision offer?
BELKIN Vision offers DSLT and Hydrus Microstent.
Who are BELKIN Vision's investors?
BELKIN Vision has 8 investors. Key investors include Alcon, Santen Pharmaceuticals, European Union, BioLight, and Zicom Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.